The aim of this study was to investigate the involvement of serotonin-1A (5-HT1A) receptors in the effects of 3,4-methylenedioxymetamphetamine (MDMA) on prepulse inhibition of acoustic startle (PPI) by comparing male and female wild-type (WT) mice and 5-HT1A receptor knockout (1AKO) mice. MDMA dose-dependently decreased PPI in male and female mice although female mice were more sensitive at the 100-ms inter-stimulus interval (ISI). In male mice, 10 mg/kg MDMA disrupted PPI in 1AKO but not in WT controls. There was no genotype difference at higher or lower doses of MDMA. In female mice, there was no difference between genotypes at any dose of MDMA. Average startle was reduced by 10 mg/kg and 20 mg/kg MDMA similarly in male and female mice an...
The serotonergic system appears crucial for (±)-3,4-methylenedioxymethamphetamine (MDMA) reinforcing...
Rationale: Amphetamine challenge in rodent prepulse inhibition (PPI) studies has been used to model ...
Serotonin (5-HT) release is the primary pharmacological mechanism of 3,4-methylenedioxymethamphetami...
Psychedelics are a subset of hallucinogenic drugs that exert their characteristic effects through ag...
International audienceAlthough numerous studies investigated the mechanisms underlying 3,4-methylene...
Methamphetamine (Meth) is a widely abused stimulant drug, but this abuse is associated with an incre...
International audienceThe amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) r...
Dopamine agonists disrupt prepulse inhibition (PPI) of startle in male rodents. In humans, this is o...
Purpose: MDMA is a psychoactive drug that has been increasingly abused worldwide, due to its entacto...
The amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) reverses dopamine and s...
Serotonin (5-HT) release is the primary pharmacological mechanism of 3,4-methylenedioxymethamphetami...
The first effects of 3,4-methylen-dioxy-metamphetamine (MDMA, "ecstasy"), on serotonin 1A (5-HT1A) r...
Rationale: Multiple lines of evidence suggest that the sex steroid hormone 17-β estradiol (E2) plays...
Recent research has highlighted a potential role for neuropeptide Y (NPY) and its Y1 receptor in the...
Rationale: Gz is a member of the Gi G protein family associated with dopamine D2-like receptors; how...
The serotonergic system appears crucial for (±)-3,4-methylenedioxymethamphetamine (MDMA) reinforcing...
Rationale: Amphetamine challenge in rodent prepulse inhibition (PPI) studies has been used to model ...
Serotonin (5-HT) release is the primary pharmacological mechanism of 3,4-methylenedioxymethamphetami...
Psychedelics are a subset of hallucinogenic drugs that exert their characteristic effects through ag...
International audienceAlthough numerous studies investigated the mechanisms underlying 3,4-methylene...
Methamphetamine (Meth) is a widely abused stimulant drug, but this abuse is associated with an incre...
International audienceThe amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) r...
Dopamine agonists disrupt prepulse inhibition (PPI) of startle in male rodents. In humans, this is o...
Purpose: MDMA is a psychoactive drug that has been increasingly abused worldwide, due to its entacto...
The amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) reverses dopamine and s...
Serotonin (5-HT) release is the primary pharmacological mechanism of 3,4-methylenedioxymethamphetami...
The first effects of 3,4-methylen-dioxy-metamphetamine (MDMA, "ecstasy"), on serotonin 1A (5-HT1A) r...
Rationale: Multiple lines of evidence suggest that the sex steroid hormone 17-β estradiol (E2) plays...
Recent research has highlighted a potential role for neuropeptide Y (NPY) and its Y1 receptor in the...
Rationale: Gz is a member of the Gi G protein family associated with dopamine D2-like receptors; how...
The serotonergic system appears crucial for (±)-3,4-methylenedioxymethamphetamine (MDMA) reinforcing...
Rationale: Amphetamine challenge in rodent prepulse inhibition (PPI) studies has been used to model ...
Serotonin (5-HT) release is the primary pharmacological mechanism of 3,4-methylenedioxymethamphetami...